Basso Capital Management’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Basso Capital Management’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-144,891	Closed	-$1.45M	–	305
2022 Q3	$1.45M	Sell	144,891 -85,052	-37%	-$852K	0.35%	108
2022 Q2	$2.29M	Buy	229,943 +30,020	+15%	+$300K	0.24%	161
2022 Q1	$2M	Hold	199,923	–	–	0.19%	193
2021 Q4	$1.97M	Buy	+199,923	New	+$1.98M	0.22%	172

Other funds holding LVAC

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Basso Capital Management's LVAC Position: Q4 2022 in Review

Basso Capital Management sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q4 2022, closing a stake of 144,891 shares — an estimated $1.45M sold.

Basso Capital Management first reported a position in LVAC in Q4 2021 and held it in 4 quarters. The position peaked at $2.29M in Q2 2022. 53 funds tracked by Wall St. Rank hold LVAC as of Q4 2022.

Basso Capital Management reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Basso Capital Management sold 144,891 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $1.45M.
Basso Capital Management first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 4 quarters.
Basso Capital Management's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $2.29M in Q2 2022.
53 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Basso Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.